Amyloid-Journal of Protein Folding Disorders

Papers
(The H4-Index of Amyloid-Journal of Protein Folding Disorders is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Impact of autonomic dysfunction in light chain amyloidosis patient with nephrotic syndrome and cardiac involvement270
Changes in the amyloid editorial board members and in editor positions262
A case of asymmetric insulin-derived localised amyloid deposition associated with long-acting insulin analog administration106
A second case of liraglutide-type localised amyloidosis93
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis − correlation between neurofilament light chain and nerve conduction study73
Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies73
Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis49
Factors associated with financial toxicity in patients with transthyretin amyloidosis: results from Amyloidosis Research Consortium’s treatment affordability patient and caregiver survey34
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases30
Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains25
Reduction of cardiac AL amyloid deposition after complete response visualised by PiB-PET imaging23
A novel transthyretin variant p.Val114Glu (Val94Glu) in an Italian patient with mixed phenotype hereditary transthyretin amyloidosis22
Early cardiovascular autonomic failure in ATTRv predicts poor prognosis and may respond to disease-modifying therapy21
Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange21
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition20
Genetic landscape of hereditary transthyretin amyloidosis in Spain: a multicentric retrospective study18
Clinical impact of beta-blocker withdrawal in transthyretin amyloid cardiomyopathy18
Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis17
0.028736114501953